Laboratory Question for the Week of December 27, 2021
Do colony count restrictions apply for coverage on 87088?
Do colony count restrictions apply for coverage on 87088?
We have a policy that we should always perform an automated differential with CBC. Is this ok from a compliance standpoint?
I’ve heard that pathologists are facing reimbursement cuts for 2022. Is this true?
Is it normal to report for each additional antibody stain when it comes to identifying the suspect neoplasm? If so, what codes would we report?
What are the risks of improper use of modifiers like modifier 59?
What are the requirements when ordering HCV screening and what are the guidelines for the frequency limit?
I’ve heard that CMS changed payment for high throughput testing, is this true? If yes, how so?
Can we report U0003 and U0004 for antibody testing?
What do U0003 and U0004 identify?
When a single case requires the processing of multiple specimens that and we code for 88362 and 88380 on the same date of service what will documentation require? Is a modifier needed?
Are there still coding and compliance risks posed with COVID-19 testing and protocol? Is there potential for audits in the future?
Can we report modifiers 76 and 77 to resolve NCCI code pair edits?
CPT® copyright 2024 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24